Traverse Biotech, INC (Traverse) is a US immunotherapy company that develops first-in-class therapies to rearm the immune system, making it part of the cure. We are raising capital to support the clinical entrance of a novel T-cell engaging (TCE) bispecific antibody, TB-Bs1, that targets ROR2 in solid tumor cancers.
Address
New YorkNew York
United States